弥漫性-话题@MedSci

#弥漫性#

118篇内容 | 2447人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1438630, encodeId=eccb1438630da, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=ESC Heart Fail：射血分数保留和肺动脉高压的心衰患者弥漫性右心室纤维化情况, objectType=article, longId=192663, objectId=1c55192663aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c55192663aa, replyNumber=0, likeNumber=79, createdTime=2020-04-22, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c55192663aa, moduleTitle=ESC Heart Fail：射血分数保留和肺动脉高压的心衰患者弥漫性右心室纤维化情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c55192663aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438629, encodeId=1f47143862939, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=ESC Heart Fail：保留射血分数和肺动脉高压的弥漫性右心室纤维化在心力衰竭中的应用, objectType=article, longId=191415, objectId=60e819141556, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60e819141556, replyNumber=0, likeNumber=49, createdTime=2020-04-05, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60e819141556, moduleTitle=ESC Heart Fail：保留射血分数和肺动脉高压的弥漫性右心室纤维化在心力衰竭中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60e819141556)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438628, encodeId=38da143862864, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=FDA接受Karyopharm的口服核出口选择性抑制剂XPOVIO的补充新药申请，用于治疗复发或难治的弥漫性大B细胞淋巴瘤, objectType=article, longId=188486, objectId=9acb18848624, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9acb18848624, replyNumber=0, likeNumber=24, createdTime=2020-02-22, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9acb18848624, moduleTitle=FDA接受Karyopharm的口服核出口选择性抑制剂XPOVIO的补充新药申请，用于治疗复发或难治的弥漫性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9acb18848624)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438627, encodeId=6812143862eef, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=Chest：生长抑素类似物改善弥漫性特发性神经内分泌细胞增生患者的呼吸道症状, objectType=article, longId=188430, objectId=7e9d1884306f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e9d1884306f, replyNumber=0, likeNumber=62, createdTime=2020-02-21, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e9d1884306f, moduleTitle=Chest：生长抑素类似物改善弥漫性特发性神经内分泌细胞增生患者的呼吸道症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e9d1884306f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438626, encodeId=31d0143862658, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=以双侧弥漫性脑白质病变为影像特征的大脑淋巴瘤病1例, objectType=article, longId=187792, objectId=5a7e18e792b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a7e18e792b3, replyNumber=0, likeNumber=69, createdTime=2020-02-11, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a7e18e792b3, moduleTitle=以双侧弥漫性脑白质病变为影像特征的大脑淋巴瘤病1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a7e18e792b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438625, encodeId=9aed143862584, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=Cell Death Dis：新型HDAC抑制剂西达本胺可与利妥昔单抗协同抑制弥漫性大B细胞淋巴瘤, objectType=article, longId=187714, objectId=782818e714bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=782818e714bf, replyNumber=0, likeNumber=23, createdTime=2020-02-10, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=782818e714bf, moduleTitle=Cell Death Dis：新型HDAC抑制剂西达本胺可与利妥昔单抗协同抑制弥漫性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=782818e714bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438624, encodeId=207d143862439, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=J Gastroenterology：PD-L1表达对原发性胃和肠弥漫性大B细胞淋巴瘤的预后影响, objectType=article, longId=187601, objectId=3fc418e60132, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fc418e60132, replyNumber=0, likeNumber=70, createdTime=2020-02-08, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fc418e60132, moduleTitle=J Gastroenterology：PD-L1表达对原发性胃和肠弥漫性大B细胞淋巴瘤的预后影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fc418e60132)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438623, encodeId=480014386239d, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=ADC Therapeutics针对CD19的抗体偶联药物loncastuximab tesirine，在弥漫性大B细胞淋巴瘤的II期临床中大获成功, objectType=article, longId=186029, objectId=4575186029eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4575186029eb, replyNumber=0, likeNumber=26, createdTime=2020-01-11, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4575186029eb, moduleTitle=ADC Therapeutics针对CD19的抗体偶联药物loncastuximab tesirine，在弥漫性大B细胞淋巴瘤的II期临床中大获成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4575186029eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438622, encodeId=0726143862228, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=Ann Rheum Dis：早期弥漫性皮肤SSc的皮肤基因表达分析显示明显的先天和适应性炎症, objectType=article, longId=183646, objectId=7a74183646ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a74183646ca, replyNumber=0, likeNumber=0, createdTime=2019-11-28, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a74183646ca, moduleTitle=Ann Rheum Dis：早期弥漫性皮肤SSc的皮肤基因表达分析显示明显的先天和适应性炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a74183646ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438621, encodeId=8d7114386216d, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=日本厚生劳动省：授予Polatuzumab vedotin治疗弥漫性大B细胞淋巴瘤的孤儿药认定, objectType=article, longId=183346, objectId=525e183346c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=525e183346c6, replyNumber=0, likeNumber=108, createdTime=2019-11-23, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=525e183346c6, moduleTitle=日本厚生劳动省：授予Polatuzumab vedotin治疗弥漫性大B细胞淋巴瘤的孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=525e183346c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438620, encodeId=8c831438620e2, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=J Gastroenterology：PD-L1表达在原发性胃和肠弥漫性大B细胞淋巴瘤中的预后影响, objectType=article, longId=179701, objectId=85981e970172, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85981e970172, replyNumber=0, likeNumber=55, createdTime=2019-09-20, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85981e970172, moduleTitle=J Gastroenterology：PD-L1表达在原发性胃和肠弥漫性大B细胞淋巴瘤中的预后影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85981e970172)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438619, encodeId=7e6b14386192d, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=弥漫性软脑膜胶质神经元肿瘤, objectType=article, longId=179515, objectId=ef311e95150a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef311e95150a, replyNumber=0, likeNumber=58, createdTime=2019-09-17, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef311e95150a, moduleTitle=弥漫性软脑膜胶质神经元肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef311e95150a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438618, encodeId=de38143861879, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=臀部弥漫性红斑，却引发了尿潴留，原因竟然是......, objectType=article, longId=177426, objectId=943e1e742653, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=943e1e742653, replyNumber=0, likeNumber=49, createdTime=2019-08-12, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=943e1e742653, moduleTitle=臀部弥漫性红斑，却引发了尿潴留，原因竟然是......, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=943e1e742653)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438617, encodeId=0b86143861e01, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=Blood：弥漫性大B细胞淋巴瘤CD37基因免疫优势位点的高发突变, objectType=article, longId=176755, objectId=ddc71e6755b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddc71e6755b1, replyNumber=0, likeNumber=83, createdTime=2019-08-04, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddc71e6755b1, moduleTitle=Blood：弥漫性大B细胞淋巴瘤CD37基因免疫优势位点的高发突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddc71e6755b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438616, encodeId=e2f1143861638, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=Thyroid：毒性弥漫性甲状腺肿患者长期接受甲巯咪唑治疗会增加缓解率, objectType=article, longId=176084, objectId=091b1e608467, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=091b1e608467, replyNumber=0, likeNumber=66, createdTime=2019-07-25, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=091b1e608467, moduleTitle=Thyroid：毒性弥漫性甲状腺肿患者长期接受甲巯咪唑治疗会增加缓解率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=091b1e608467)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438615, encodeId=da5d1438615f4, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=临床实践指南：成人弥漫性胶质瘤相关癫痫的诊断和治疗（英文版）, objectType=article, longId=174595, objectId=189d1e459511, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=189d1e459511, replyNumber=0, likeNumber=23, createdTime=2019-07-01, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=189d1e459511, moduleTitle=临床实践指南：成人弥漫性胶质瘤相关癫痫的诊断和治疗（英文版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=189d1e459511)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438614, encodeId=82cf143861456, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=来那度胺在弥漫性大B细胞淋巴瘤中的应用, objectType=article, longId=168705, objectId=eb1e168e0594, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb1e168e0594, replyNumber=0, likeNumber=70, createdTime=2019-06-20, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb1e168e0594, moduleTitle=来那度胺在弥漫性大B细胞淋巴瘤中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb1e168e0594)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438613, encodeId=01db143861310, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=来那度胺在弥漫性大B细胞淋巴瘤中的应用继续闪耀, objectType=article, longId=168636, objectId=b21a168636d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b21a168636d1, replyNumber=0, likeNumber=59, createdTime=2019-06-19, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b21a168636d1, moduleTitle=来那度胺在弥漫性大B细胞淋巴瘤中的应用继续闪耀, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b21a168636d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438612, encodeId=d3b114386121a, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=Lancet oncol：Polatuzumab vedotin联合免疫化疗用于弥漫性大B细胞淋巴瘤的安全性和疗效, objectType=article, longId=166508, objectId=9b0116650850, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b0116650850, replyNumber=0, likeNumber=49, createdTime=2019-05-22, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b0116650850, moduleTitle=Lancet oncol：Polatuzumab vedotin联合免疫化疗用于弥漫性大B细胞淋巴瘤的安全性和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b0116650850)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1438611, encodeId=19351438611e9, content=<a href='/topic/show?id=9851500416c' target=_blank style='color:#2F92EE;'>#弥漫性#</a>, objectTitle=弥漫性淋巴管瘤病合并后胡桃夹综合征1例, objectType=article, longId=166140, objectId=02601661409e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02601661409e, replyNumber=0, likeNumber=61, createdTime=2019-05-16, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02601661409e, moduleTitle=弥漫性淋巴管瘤病合并后胡桃夹综合征1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02601661409e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

弥漫性

2020-05-29

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

ESC Heart Fail：射血分数保留和肺动脉高压的心衰患者弥漫性右心室纤维化情况

2020-04-22

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

ESC Heart Fail：保留射血分数和肺动脉高压的弥漫性右心室纤维化在心力衰竭中的应用

2020-04-05

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

FDA接受Karyopharm的口服核出口选择性抑制剂XPOVIO的补充新药申请，用于治疗复发或难治的弥漫性大B细胞淋巴瘤

2020-02-22

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

Chest：生长抑素类似物改善弥漫性特发性神经内分泌细胞增生患者的呼吸道症状

2020-02-21

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

以双侧弥漫性脑白质病变为影像特征的大脑淋巴瘤病1例

2020-02-11

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

Cell Death Dis：新型HDAC抑制剂西达本胺可与利妥昔单抗协同抑制弥漫性大B细胞淋巴瘤

2020-02-10

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

J Gastroenterology：PD-L1表达对原发性胃和肠弥漫性大B细胞淋巴瘤的预后影响

2020-02-08

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

ADC Therapeutics针对CD19的抗体偶联药物loncastuximab tesirine，在弥漫性大B细胞淋巴瘤的II期临床中大获成功

2020-01-11

爆笑小医 (审核中...)

前往app查看评论内容

#弥漫性#

Ann Rheum Dis：早期弥漫性皮肤SSc的皮肤基因表达分析显示明显的先天和适应性炎症

2019-11-28

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

日本厚生劳动省：授予Polatuzumab vedotin治疗弥漫性大B细胞淋巴瘤的孤儿药认定

2019-11-23

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

J Gastroenterology：PD-L1表达在原发性胃和肠弥漫性大B细胞淋巴瘤中的预后影响

2019-09-20

docwu2019 (审核中...)

前往app查看评论内容

#弥漫性#

弥漫性软脑膜胶质神经元肿瘤

2019-09-17

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

臀部弥漫性红斑，却引发了尿潴留，原因竟然是......

2019-08-12

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

Blood：弥漫性大B细胞淋巴瘤CD37基因免疫优势位点的高发突变

2019-08-04

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

Thyroid：毒性弥漫性甲状腺肿患者长期接受甲巯咪唑治疗会增加缓解率

2019-07-25

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

临床实践指南：成人弥漫性胶质瘤相关癫痫的诊断和治疗（英文版）

2019-07-01

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

来那度胺在弥漫性大B细胞淋巴瘤中的应用

2019-06-20

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

来那度胺在弥漫性大B细胞淋巴瘤中的应用继续闪耀

2019-06-19

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

Lancet oncol：Polatuzumab vedotin联合免疫化疗用于弥漫性大B细胞淋巴瘤的安全性和疗效

2019-05-22

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性#

弥漫性淋巴管瘤病合并后胡桃夹综合征1例

2019-05-16

科室
- - 订阅+
  - 更多科室
工具
服务